Skip to content

Study · In vitro (cells) · 2022

5 results

AMPK-autophagy-mediated inhibition of microRNA-30a-5p alleviates morphine tolerance via SOCS3-dependent neuroinflammation suppression.

Wan L, Jia RM, Ji LL, Qin XM, Hu L, Hu F, Han Y, Pan YB, Jiang CY, Liu WT

Journal of neuroinflammation29 Jan 2022Cited by 30 (Europe PMC)

Summary

BackgroundThe development of morphine tolerance is a clinical challenge for managing severe pain. Studies have shown that neuroinflammation is a critical aspect for the development of analgesic tolerance. We found that AMPK-autophagy activation could suppress neuroinflammation and improve morphine tolerance via the upregulation of suppressor of cytokine signaling 3 (SOCS3) by inhibiting the processing and maturation of microRNA-30a-5p.MethodsCD-1 mice were utilized for the tail-flick test to evaluate morphine tolerance. The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3. Proinflammatory cytokines were measured by western blotting and real-time PCR. The levels of SOCS3 and miRNA-processing enzymes were evaluated by western blotting, real-time PCR and immunofluorescence staining.ResultsBased on experimental verification, miRNA-30a-5p could negatively regulate SOCS3. The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p. We found that AMPK activators specifically inhibited the processing and maturation of miRNA-30a-5p in microglia by degrading DICER and AGO2 via autophagy. Furthermore, a miRNA-30a-5p inhibitor significantly improved morphine tolerance via upregulation of SCOS3 in mice. It markedly increased the level of SOCS3 in the spinal cord of mice and subsequently inhibited morphine-induced phosphorylation of NF-κB p65. In addition, a miRNA-30a-5p inhibitor decreased the levels of IL-1β and TNF-α caused by morphine in microglia.ConclusionAMPK-autophagy activation suppresses neuroinflammation and improves morphine tolerance via the upregulation of SOCS3 by inhibiting miRNA-30a-5p.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study5

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In microglia, AICAR downregulated miRNA-30a-5p.

    In plain wordsIn cells, AICAR reduced miRNA-30a-5p levels.

    Outcome
    DecreasemiRNA-30a-5p levels
    Study

    n: not reported in source

    BV-2 microglia
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p.
    1 context sentence
    Summary · context
    The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3.

Studies that did not test the peptide alone4

In this study, AICAR (acadesine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking AICAR (acadesine).

  1. 02LabNot a test of AICAR (acadesine) aloneIn vitro (cells)Mechanism

    In microglia, AMPK activators including AICAR inhibited miRNA-30a-5p processing through autophagy.

    In plain wordsIn cells, AMPK activators including AICAR inhibited miRNA-30a-5p processing.

    Outcome
    DecreasemiRNA-30a-5p processing
    Study

    n: not reported in source

    BV-2 microglia
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    We found that AMPK activators specifically inhibited the processing and maturation of miRNA-30a-5p in microglia by degrading DICER and AGO2 via autophagy.
    2 context sentences
    Summary · context
    The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p.
    Summary · context
    The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3.

    In this study, AICAR (acadesine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AICAR (acadesine).

  2. 03LabNot a test of AICAR (acadesine) aloneIn vitro (cells)Mechanism

    In microglia, AMPK activators including AICAR inhibited miRNA-30a-5p maturation through autophagy.

    In plain wordsIn cells, AMPK activators including AICAR inhibited miRNA-30a-5p maturation.

    Outcome
    DecreasemiRNA-30a-5p maturation
    Study

    n: not reported in source

    BV-2 microglia
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    We found that AMPK activators specifically inhibited the processing and maturation of miRNA-30a-5p in microglia by degrading DICER and AGO2 via autophagy.
    2 context sentences
    Summary · context
    The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p.
    Summary · context
    The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3.

    In this study, AICAR (acadesine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AICAR (acadesine).

  3. 04LabNot a test of AICAR (acadesine) aloneIn vitro (cells)Mechanism

    In microglia, AMPK activators including AICAR degraded DICER through autophagy.

    In plain wordsIn cells, AMPK activators including AICAR promoted DICER degradation through autophagy.

    Outcome
    IncreaseDICER degradation
    Study

    n: not reported in source

    BV-2 microglia
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    We found that AMPK activators specifically inhibited the processing and maturation of miRNA-30a-5p in microglia by degrading DICER and AGO2 via autophagy.
    2 context sentences
    Summary · context
    The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p.
    Summary · context
    The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3.

    In this study, AICAR (acadesine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AICAR (acadesine).

  4. 05LabNot a test of AICAR (acadesine) aloneIn vitro (cells)Mechanism

    In microglia, AMPK activators including AICAR degraded AGO2 through autophagy.

    In plain wordsIn cells, AMPK activators including AICAR promoted AGO2 degradation through autophagy.

    Outcome
    IncreaseAGO2 degradation
    Study

    n: not reported in source

    BV-2 microglia
    Outcome group
    Receptor activity and mechanism · Nervous system and cognition

    Source sentences

    Summary
    We found that AMPK activators specifically inhibited the processing and maturation of miRNA-30a-5p in microglia by degrading DICER and AGO2 via autophagy.
    2 context sentences
    Summary · context
    The AMPK activators AICAR, resveratrol and metformin downregulated miRNA-30a-5p.
    Summary · context
    The microglial cell line BV-2 was utilized to investigate the mechanism of AMPK-autophagy-mediated posttranscriptional regulation of SOCS3.

    In this study, AICAR (acadesine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking AICAR (acadesine).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.